First-Line Sunvozertinib in NSCLC with <i>EGFR</i> Exon 20 Insertion Mutations
- DOI
- 10.1056/nejmoa2604461
- Published
- 2026-08-20
- Container
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1056/nejmoa2604461,
title = {First-Line Sunvozertinib in NSCLC with
<i>EGFR</i>
Exon 20 Insertion Mutations},
author = {Caicun Zhou and Laurent Greillier and Geoffrey Liu and Thomas John and Ligang Xing and Dariusz Kowalski and Regan M. Memmott and Ozan Yazici and Meili Sun and Catherine A. Shu and Elvire Pons-Tostivint and Yun Fan and Gonzalo Fernandez-Hinojal and Elaine Shum and Mengzhao Wang and Federica Bertolini and D. Ross Camidge and Chengzhi Zhou and Ludovic Doucet and Qunying Hong and Jian Fang and Dingzhi Huang and Bo Jin and Yan Yu and Lorenzo Antonuzzo and Denis Moro-Sibilot and Jaafar Bennouna and Gilberto de Castro and Li Zheng and John V. Heymach},
year = {2026},
journal = {New England Journal of Medicine},
doi = {10.1056/nejmoa2604461},
url = {https://doi.org/10.1056/nejmoa2604461}
}RIS
TY - JOUR
TI - First-Line Sunvozertinib in NSCLC with
<i>EGFR</i>
Exon 20 Insertion Mutations
AU - Caicun Zhou
AU - Laurent Greillier
AU - Geoffrey Liu
AU - Thomas John
AU - Ligang Xing
AU - Dariusz Kowalski
AU - Regan M. Memmott
AU - Ozan Yazici
AU - Meili Sun
AU - Catherine A. Shu
AU - Elvire Pons-Tostivint
AU - Yun Fan
AU - Gonzalo Fernandez-Hinojal
AU - Elaine Shum
AU - Mengzhao Wang
AU - Federica Bertolini
AU - D. Ross Camidge
AU - Chengzhi Zhou
AU - Ludovic Doucet
AU - Qunying Hong
AU - Jian Fang
AU - Dingzhi Huang
AU - Bo Jin
AU - Yan Yu
AU - Lorenzo Antonuzzo
AU - Denis Moro-Sibilot
AU - Jaafar Bennouna
AU - Gilberto de Castro
AU - Li Zheng
AU - John V. Heymach
PY - 2026
JO - New England Journal of Medicine
DO - 10.1056/nejmoa2604461
UR - https://doi.org/10.1056/nejmoa2604461
ER - APA
Zhou, C., Greillier, L., Liu, G., John, T., Xing, L., Kowalski, D., Memmott, R. M., Yazici, O., Sun, M., Shu, C. A., Pons-Tostivint, E., Fan, Y., Fernandez-Hinojal, G., Shum, E., Wang, M., Bertolini, F., Camidge, D. R., Zhou, C., Doucet, L., Hong, Q., Fang, J., Huang, D., Jin, B., Yu, Y., Antonuzzo, L., Moro-Sibilot, D., Bennouna, J., Castro, G. D., Zheng, L., & Heymach, J. V. (2026). First-Line Sunvozertinib in NSCLC with <i>EGFR</i> Exon 20 Insertion Mutations. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2604461
Source records
- crossref · retrieved 2026-09-25T05:21:24.273Z